SCI Pharmtech, Inc. (TPE:4119)

SCI Pharmtech Revenue

SCI Pharmtech had revenue of 272.87M TWD in the quarter ending June 30, 2026, a decrease of -26.55%. This brings the company's total for the last twelve months to 1.26B, down -18.83% year-over-year. In the year 2025, SCI Pharmtech had annual revenue of 1.34B, down -11.81%. That makes SCI Pharmtech the 29,686th largest company in the world by revenue and 1,445th in Taiwan.

• Revenue (ttm): 1.26B
• Revenue Growth: -18.83%
• P/S Ratio: 5.01
• Revenue / Employee: 5.27M
• Employees: 245
• Market Cap: 6.35B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Italy 218.93M 16.3%
• United States 212.36M 15.8%
• Japan 208.55M 15.5%
• Other Countries 206.04M 15.3%
• Taiwan 114.62M 8.5%
• Germany 99.66M 7.4%
• Spain 90.32M 6.7%
• Other 193.24M 14.4%

Fiscal year ended Dec 31, 2025 See the full SCI Pharmtech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.34B	-180.02M	-11.81%
Dec 31, 2024	1.52B	319.58M	26.54%
Dec 31, 2023	1.20B	304.42M	33.83%
Dec 31, 2022	899.74M	35.52M	4.11%
Dec 31, 2021	864.22M	-1.83B	-67.86%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error